RE:RE:UPDATE From Mr. Fia for all long term investors.... Fia talks a big game but has yet to deliver. JV or buyout imo will kill shareholder value. Just like the predatory offer from hcw that Rob took which had a big role with current share price.
Here we are at .14 and you want to share profits with another producer or even sell Acuvid if approved. Who would be buying this out exactly? Any large player will simply create their own test.
Fia is a one man show. Line his pockets first shareholders get bags. When a ceo won't pay market price of .13 for his own company I lose all faith in the story. "His order didn't fill" pay the extra half penny you big ceo.
TheLandedEagles wrote: What I found interesting in video update is that they (FIA), also stated that they are in general discussion and receptive to a possible JV or buyout posibility with related parties in this space...quite possible once FDA approval is secured...they may... announce this at same time, or shortly thereafter approval. Wouldnt surprise me, if bigger player takes over MFG and distribution of this new saliva test...will definately require more capital anyhow, if they go full speed with production....that will cause more dilution of course and therefore, a sale may be more adventagous for all shareholders in my opinion... Fia, is probably looking at this as his exist stratagy....just my thoughts...